Below is Validea's guru fundamental report for SYNOPSYS INC (SNPS). Of the 22 guru strategies we follow, SNPS rates highest using our Twin Momentum Investor model based on the published strategy of ...

If the concept of personalized medicine is to be realized, it is increasingly clear that single nucleotide polymorphisms (SNPs), the most common genetic variations between human beings, will be a key ...

Mice and rats are a fundamental component of drug discovery research. Standard outbred stocks and inbred strains of rodents are used extensively for drug safety and pharmacokinetic testing. Our ...

Synopsys Inc. SNPS reports preliminary financial results for the year ended 2012-10-31. Synopsys Inc. recently reported its preliminary financial results based on which we provide a unique peer-based ...

This is a technical analysis article. Our “Implied Return” computer program picked Synopsys, Inc. stock for us, and we added it to our 2024 Model Portfolio. The computer uses both technical and ...

Milliman’s analysis of SNP Alliance member organization risk score data from CMS suggests that while the impact of the new risk score model will vary significantly by plan and by MA organization, it ...